Interobserver variability among measurements of the maximum and mean standardized uptake values on (18)F-FDG PET/CT and measurements of tumor size on diagnostic CT in patients with pulmonary tumors.

Autor: Huang YE, Chen CF, Huang YJ, Konda SD, Appelbaum DE, Pu Y, Huang, Yu-Erh, Chen, Chih-Feng, Huang, Yu-Jie, Konda, Sheela D, Appelbaum, Daniel E, Pu, Yonglin

Publikováno v: Acta Radiologica; Sep2010, Vol. 51 Issue 7, p782-788, 7p

MEN1/DAXX/ATRX mutations enhance progression-free survival in gastroenteropancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy.

Autor: Gujarathi R; Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, USA., Abou Azar S; Section of Endocrine Surgery, Department of Surgery, University of Chicago, Chicago, Illinois, USA., Tobias J; Section of Endocrine Surgery, Department of Surgery, University of Chicago, Chicago, Illinois, USA., Polite BN; Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, USA., Setia N; Department of Pathology, University of Chicago, Chicago, Illinois, USA., Feinberg N; Department of Radiology, University of Chicago, Chicago, Illinois, USA., Appelbaum DE; Department of Radiology, University of Chicago, Chicago, Illinois, USA., Keutgen XM; Section of Endocrine Surgery, Department of Surgery, University of Chicago, Chicago, Illinois, USA., Liao CY; Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, USA.

Publikováno v: Endocrine-related cancer [Endocr Relat Cancer] 2024 Oct 04; Vol. 31 (11). Date of Electronic Publication: 2024 Oct 04 (Print Publication: 2024).

Optimization of Metabolic Tumor Volume as a Prognostic Marker in CAR T-Cell Therapy for Aggressive Large B-cell NHL.

Autor: Rojek AE; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL., Kline JP; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL., Feinberg N; Department of Radiology, Section of Nuclear Medicine, University of Chicago, Chicago, IL., Appelbaum DE; Department of Radiology, Section of Nuclear Medicine, University of Chicago, Chicago, IL., Pu Y; Department of Radiology, Section of Nuclear Medicine, University of Chicago, Chicago, IL., Derman BA; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL., Jakubowiak A; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL., Kosuri S; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL., Liu H; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL., Nawas MT; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL., Smith SM; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL., Bishop MR; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL., Riedell PA; Department of Medicine, Section of Hematology-Oncology, University of Chicago, Chicago, IL; David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL. Electronic address: Peter.Riedell@bsd.uchicago.edu.

Publikováno v: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Feb; Vol. 24 (2), pp. 83-93. Date of Electronic Publication: 2023 Sep 16.

Evaluation of the gallbladder and cystic duct patency with gadoxetate disodium enhanced MR cholangiography: prospective comparison of patients with normal gallbladder function and acute cholecystitis.

Autor: Yacoub JH; Department of Radiology, University of Chicago, Chicago, IL, USA joeyacoub@gmail.com., Yousuf A; Department of Radiology, University of Chicago, Chicago, IL, USA., Agrawal G; Mallinckrodt Institute of Radiology, Washington University in Saint Louis, Saint Louis, MO, USA., Thomas S; Department of Radiology, University of Chicago, Chicago, IL, USA., Appelbaum DE; Department of Radiology, University of Chicago, Chicago, IL, USA., Oto A; Department of Radiology, University of Chicago, Chicago, IL, USA.

Publikováno v: Acta radiologica (Stockholm, Sweden : 1987) [Acta Radiol] 2015 Jul; Vol. 56 (7), pp. 782-9. Date of Electronic Publication: 2014 Jul 09.

Advanced neuroimaging studies in a patient with brain metastases from transitional cell carcinoma of the bladder.

Autor: Choi YJ; Departments of Neurology, University of Chicago, Chicago, IL., Gabikian P, Zhu F, Appelbaum DE, Wollmann R, Lukas RV

Publikováno v: Journal of neuroimaging : official journal of the American Society of Neuroimaging [J Neuroimaging] 2014 Jul-Aug; Vol. 24 (4), pp. 429-31. Date of Electronic Publication: 2013 Apr 02.